Elanix Biotechnologies (ELN.F) stock price, revenue, and financials

Elanix Biotechnologies market cap is €5.2 m, and annual revenue was €328.15 k in FY 2017

€5.2 M

ELN.F Mkt cap, 27-Nov-2020

€328.1 K

Elanix Biotechnologies Revenue FY, 2017
Elanix Biotechnologies Revenue growth (FY, 2016 - FY, 2017), %5171%
Elanix Biotechnologies Gross profit (FY, 2017)170.5 K
Elanix Biotechnologies Gross profit margin (FY, 2017), %52%
Elanix Biotechnologies Net income (FY, 2017)3.8 M
Elanix Biotechnologies EBIT (FY, 2017)4.4 M
Elanix Biotechnologies Cash, 31-Dec-2017212.2 K

Elanix Biotechnologies Revenue

Elanix Biotechnologies revenue was €328.15 k in FY, 2017 which is a 5170.6% year over year increase from the previous period.

Embed Graph

Elanix Biotechnologies Revenue Breakdown

Embed Graph

Elanix Biotechnologies revenue breakdown by business segment: 79.6% from Selling Products and 20.4% from Licences

Elanix Biotechnologies Income Statement

Annual

EURFY, 2016FY, 2017

Revenue

6.2k328.1k

Revenue growth, %

5171%

Cost of goods sold

3.5k157.6k

Gross profit

2.7k170.5k

Gross profit Margin, %

44%52%

General and administrative expense

2.3m4.6m

Operating expense total

2.3m4.7m

EBIT

2.3m4.4m

EBIT margin, %

37313%1338%

Pre tax profit

2.3m4.7m

Income tax expense

454.9k830.4k

Net Income

1.9m3.8m

Elanix Biotechnologies Balance Sheet

Annual

EURFY, 2016FY, 2017

Cash

73.6k212.2k

Accounts Receivable

140.0201.5k

Inventories

33.5k138.7k

Current Assets

177.6k1.3m

PP&E

15.2k39.7k

Total Assets

21.8m22.4m

Accounts Payable

250.3k576.5k

Current Liabilities

1.0m1.7m

Non-Current Liabilities

5.4m4.7m

Total Liabilities

6.4m6.4m

Common Stock

5.7m6.8m

Total Equity

15.4m16.0m

Financial Leverage

1.4 x1.4 x

Elanix Biotechnologies Cash Flow

Annual

EURFY, 2016FY, 2017

Cash From Operating Activities

(823.9k)(3.8m)

Purchases of PP&E

(19.0k)(35.3k)

Cash From Investing Activities

(131.5k)(35.3k)

Long-term Borrowings

(597.4k)(767.7k)

Cash From Financing Activities

956.1k(3.9m)

Net Change in Cash

760.0138.6k

Elanix Biotechnologies Ratios

EURFY, 2016

Revenue/Employee

1.2k

Financial Leverage

1.4 x